Diabetes Drug May Help Fight Lung Cancer in Overweight Patients: Study

Metformin may improve immune responses in lung cancer patients with obesity. Read about the implications for future clinical trials.

Sonis Photography/Shutterstock

A common diabetes medication may offer new hope for overweight patients battling lung cancer.

Researchers have found that metformin, a decades-old drug used to control blood sugar, could improve immunotherapy outcomes and extend recurrence-free survival in lung cancer patients carrying extra weight.